The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression
Abstract
Leptin-deficient ob/ob mice show many characteristics of obesity, including excess peripheral adiposity as well as severe hepatic steatosis, at least in part, due to increased hepatic lipogenesis. Polyunsaturated fatty acids (PUFAs) are not only ligands for peroxisome proliferator-activated receptor (PPAR) alpha but are also negative regulators of hepatic lipogenesis, which is thought to be mediated by the repression of sterol regulatory element-binding protein (SREBP)-1. We have previously shown that the disruption of SREBP-1 in ob/ob mice decreased their liver triglyceride storage. To examine whether PUFAs could reduce hepatic triglyceride deposition, we challenged ob/ob mice with dietary PUFA. It is demonstrated that PUFA markedly decreased the mature form of SREBP-1 protein and thereby reduced the expression of lipogenic genes such as fatty acid synthase (FAS) and stearoyl-CoA desaturase 1 (SCD1) in the livers of ob/ob mice. Consequently, the liver triglyceride content and plasma alanine aminotransferase (ALT) levels were decreased. Furthermore, both hyperglycemia and hyperinsulinemia in ob/ob mice were improved by PUFA administration, similar to the effect of PPARalpha activators. In conclusion, PUFAs ameliorate obesity-associated symptoms, such as hepatic steatosis and insulin resistance, presumably through both down-regulation of SREBP-1 and activation of PPARalpha.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mechanistic underpinnings involve the downregulation of SREBP-1c and activation of PPARα (98).”
From Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility (2024) · cites this paper as [98]
In the citing paper
“Moreover, these fatty acids have demonstrated efficacy in enhancing insulin sensitivity, ameliorating steatohepatitis, and reducing intrahepatic triglyceride content.”
From Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility (2024) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis
Bray, G. A., & York, D. A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.719 · Cited by 1,132
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J.-Α. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 861
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 817
Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119247 · Cited by 766
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 414
Nutrigenomics of ω-3 fatty acids: Regulators of the master transcription factors
Rodríguez‐Cruz, M., & Serna, D. S. (2017) · Nutrition · doi:10.1016/j.nut.2017.04.012 · Cited by 78
Roth, A. B., Looser, R., Kaufmann, M., & Meyer, U. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f706e0 · Cited by 73
Kajikawa, S., Harada, T., Kawashima, A., Imada, K., & Mizuguchi, K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.02.004 · Cited by 72
Differential Effects of Krill Oil and Fish Oil on the Hepatic Transcriptome in Mice
Burri, L., Berge, K., Wibrand, K., Berge, R. K., & Barger, J. L. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00045 · Cited by 73
Larter, C. Z., Yeh, M. M., Cheng, J., Williams, J., Brown, S., Dela Pena, A., Bell‐Anderson, K. S., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05157.x · Cited by 70
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Campos-Murguía, A., Ruiz‐Margáin, A., González-Regueiro, J. A., & Macías‐Rodríguez, R. U. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i39.5919 · Cited by 75
Kaur, G., Sinclair, A. J., Cameron‐Smith, D., Barr, D. P., Molero, J. C., & Konstantopoulos, N. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.06.002 · Cited by 70
Mambrini, S. P., Grillo, A., Colosimo, S., Zarpellon, F., Pozzi, G., Furlan, D., Amodeo, G., & Bertoli, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1426551 · Cited by 70
Suzuki‐Kemuriyama, N., Matsuzaka, T., Kuba, M., Ohno, H., Han, S., Takeuchi, Y., Isaka, M., Kobayashi, K., IWASAKI, H. O., Yatoh, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157580 · Cited by 69
Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use
Worthmann, A., Ridder, J., Piel, S., Evangelakos, I., Musfeldt, M., Voß, H., O’Farrell, M., Fischer, A. W., Adak, S., Sundd, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44364-y · Cited by 69
Morisco, F., Vitaglione, P., Amoruso, D., Russo, B., Fogliano, V., & Caporaso, N. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.003 · Cited by 67
Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis
Ducheix, S., Lobaccaro, J. A., Martin, P. G. P., & Guillou, H. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.06.004 · Cited by 71
van Schothorst, E. M., Flachs, P., Franssen-van Hal, N. L., Kuda, O., Bunschoten, A., Molthoff, J., Vink, C., Hooiveld, G. J., Kopecky, J., & Keijer, J. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-110 · Cited by 64
Chen, X., Zhang, C., Zhao, M., Shi, C.-E., Zhu, R.-M., Wang, H., Zhao, H., Wei, W., Li, J., & Xu, D. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00905.x · Cited by 64
Hwang, B., Jeoung, N. H., & Harris, R. A. (2009) · Biochemical Journal · doi:10.1042/bj20090390 · Cited by 61
Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J. L., Vacca, M., & Vidal‐Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 67
Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis
Vergani, L. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170518101334 · Cited by 64
Casali, B. T., Corona, A. W., Mariani, M. M., Karlo, J. C., Ghosal, K., & Landreth, G. E. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1000-15.2015 · Cited by 63
Park, M.-Y., & Mun, S. T. (2013) · Nutrition Research and Practice · doi:10.4162/nrp.2013.7.4.294 · Cited by 59
Schroeder, F., McIntosh, A. L., Martin, G. G., Huang, H., Landrock, D., Chung, S., Landrock, K. K., Dangott, L. J., Li, S., Kaczocha, M., et al. (2016) · Lipids · doi:10.1007/s11745-016-4155-8 · Cited by 61
Hua, P., Yu, Z., Xiong, Y. C., Liu, B., & Zhao, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124023 · Cited by 61
Insulin resistance and steatosis in hepatitis C virus infection
Zekry, A., McHutchison, J. G., & Diehl, A. M. (2005) · Gut · doi:10.1136/gut.2004.059873 · Cited by 58
Pérez‐Martínez, P., Pérez‐Jiménez, F., & López‐Miranda, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.010 · Cited by 57
Mocciaro, G., Allison, M., Jenkins, B., Azzu, V., Huang‐Doran, I., Herrera-Marcos, L. V., Hall, Z., Murgia, A., Davies, S. E., Frontini, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101728 · Cited by 56
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Li, X., & Wang, H. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00507-y · Cited by 59
Zhang, B., Wei, G., Li, R., Wang, Y., Yu, J. G., Wang, R., 肖华, Leng, C., Leng, C., Zhang, B., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.08.002 · Cited by 55
The role of Omega-3 and Omega-9 fatty acids for the treatment of neuropathic pain after neurotrauma
Galán-Arriero, I., Serrano‐Muñoz, D., Gómez‐Soriano, J., Goicoechea, C., Taylor, J., Velasco, A. L., & Ávila-Martín, G. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.05.003 · Cited by 54
Jeyakumar, S. M., & Vajreswari, A. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i1.168 · Cited by 56
DHA regulates lipogenesis and lipolysis genes in mice adipose and liver
Sun, C., Zhou-wen, W., & Li, Y. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0160-9 · Cited by 54
Dong, X., Xu, H., Mai, K., Xu, W., Zhang, Y., & Ai, Q. (2014) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2014.10.001 · Cited by 53
van den Hoek, A. M., de Jong, J. C. B. C., Worms, N., van Nieuwkoop, A., Voskuilen, M., Menke, A. L., Lek, S., Caspers, M. P. M., Verschuren, L., & Kleemann, R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154873 · Cited by 54
Pærregaard, S. I., Agerholm, M., Serup, A. K., Ma, T., Kiens, B., Madsen, L., Kristiansen, K., & Jensen, B. A. H. (2016) · Mediators of Inflammation · doi:10.1155/2016/1536047 · Cited by 54
Kajikawa, S., Imada, K., Takeuchi, T., Shimizu, Y., Kawashima, A., Harada, T., & Mizuguchi, K. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1400-5 · Cited by 51
Chen, Y.-J., Liu, H., Chang, Y., Cheng, Y.-H., Mersmann, H. J., Kuo, W., & Ding, S. (2016) · Journal of Visualized Experiments · doi:10.3791/53886 · Cited by 51
The potential role of genes in nonalcoholic fatty liver disease
Day, C. P. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.001 · Cited by 51
Marsman, H. A., de Graaf, W., Heger, M., van Golen, R. F., ten Kate, F. J. W., Bennink, R. J., & van Gulik, T. M. (2013) · British journal of surgery · doi:10.1002/bjs.9059 · Cited by 50
SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling
Shimano, H. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0158-5 · Cited by 50
Miyoshi, H., Moriya, K., Tsutsumi, T., Shinzawa, S., Fujie, H., Shintani, Y., Fujinaga, H., Goto, K., Todoroki, T., Suzuki, T., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.039 · Cited by 49
Ducheix, S., Montagner, A., Polizzi, A., Lasserre, F., Marmugi, A., Bertrand‐Michel, J., Podechard, N., Saati, T. A., Chétiveaux, M., Baron, S., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.006 · Cited by 51
Nascimento, F. A. M., Barbosa‐da‐Silva, S., Fernandes‐Santos, C., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2008.12.008 · Cited by 49
Plant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies
Fardet, A., & Chardigny, J. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.549596 · Cited by 46
Yan, S.-L., Yang, H.-T., Lee, Y.-J., Lin, C.-C., Chang, M.-H., & Yin, M.-C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501165z · Cited by 46
Marsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., van Werven, J. R., Nederveen, A. J., ten Kate, F. J. W., Stoker, J., & van Gulik, T. M. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06326.x · Cited by 46
Masi, L. N., Martins, A. R., Neto, J. C. R., do Amaral, C. L., Crisma, A. R., Vinolo, M. A. R., Júnior, E. A. D. L., Hirabara, S. M., & Curi, R. (2012) · BioMed Research International · doi:10.1155/2012/945131 · Cited by 47
Hussain, A., Nookaew, I., Khoomrung, S., Andersson, L., Larsson, I., Hulthén, L., Jansson, N., Jakubowicz, R., Nilsson, S., Sandberg, A., et al. (2013) · Acta Physiologica · doi:10.1111/apha.12130 · Cited by 46
Lombardi, R., Iuculano, F., Pallini, G., Fargion, S. R., & Fracanzani, A. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228761 · Cited by 47
Marsman, H. A., Heger, M., Kloek, J. J., Nienhuis, S., ten Kate, F. J. W., & van Gulik, T. M. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.07.009 · Cited by 45
Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors
Krysa, J. A., Ooi, T. C., Proctor, S. D., & Vine, D. F. (2017) · Journal of Nutrition · doi:10.3945/jn.116.235069 · Cited by 49
Nóbrega, R. O., Batista, R. O., Côrrea, C. F., Mattioni, B., Filer, K., Pettigrew, J. E., & Fracalossi, D. M. (2019) · Aquaculture · doi:10.1016/j.aquaculture.2019.04.030 · Cited by 45
Kuba, M., Matsuzaka, T., Matsumori, R., Saito, R., Kaga, N., Taka, H., Ikehata, K., Okada, N., Kikuchi, T., Ohno, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17604 · Cited by 46
Martin, G. G., McIntosh, A. L., Huang, H., Gupta, S., Atshaves, B. P., Landrock, K. K., Landrock, D., Kier, A. B., & Schroeder, F. (2013) · Biochemistry · doi:10.1021/bi401014k · Cited by 44
Bioactive signalling lipids as drivers of chronic liver diseases
Kaffe, E., Tisi, A., Magkrioti, C., Aidinis, V., Mehal, W. Z., Flavell, R. A., & Maccarrone, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.029 · Cited by 45
A Critical Role for Matrix Metalloproteinases in Liver Regeneration
Alwayn, I. P. J., Verbesey, J. E., Kim, S., Roy, R., Arsenault, D. A., Greene, A. K., Novak, K., Laforme, A., Lee, S., Moses, M. A., et al. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.002 · Cited by 43
Lipidomic Profiling of PFOA-Exposed Mouse Liver by Multi-Modal Mass Spectrometry Analysis
Stoffels, C., Angerer, T. B., Robert, H., Poupin, N., Lakhal, L., Frache, G., Mercier‐Bonin, M., & Audinot, J. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05470 · Cited by 42
Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?
Gibson, P. R. (2005) · Gut · doi:10.1136/gut.2004.058453 · Cited by 41
Pros and cons of fatty acids in bone biology
Wauquier, F., Léotoing, L., Philippe, C., Spilmont, M., Coxam, V., & Wittrant, Y. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.03.001 · Cited by 41
Deng, X., Wang, J., Li, J., Utaipan, T., Tuma‐Kellner, S., Schmitz, G., Liebisch, G., Stremmel, W., & Chamulitrat, W. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.004 · Cited by 42
Bellini, L., Campaña, M. B., Rouch, C., Chacińska, M., Bugliani, M., Meneyrol, K., Hainault, I., Lenoir, V., Denom, J., Véret, J., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4629-8 · Cited by 41
Eslami, O., Shidfar, F., Maleki, Z., Jazayeri, S., Hosseini, A. F., Agah, S., & Ardiyani, F. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1479990 · Cited by 41
Chen, Z., Luo, J., Ma, L., Wang, H., Cao, W., Xu, H., Zhu, J., Sun, Y., Li, J., Yao, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142809 · Cited by 42
Tajima-Shirasaki, N., Ishii, K., Takayama, H., Shirasaki, T., Iwama, H., Chikamoto, K., Saito, Y., Iwasaki, Y., Teraguchi, A., Lan, F., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.747006 · Cited by 39
Yang, J., Sáinź, N., Félix‐Soriano, E., Gil‐Iturbe, E., Castilla‐Madrigal, R., Fernández‐Galilea, M., Martínez, J. A., & Moreno-Aliaga, M. J. (2021) · Nutrients · doi:10.3390/nu13020501 · Cited by 40
Saito, R., Matsuzaka, T., Karasawa, T., Sekiya, M., Okada, N., Igarashi, M., Matsumori, R., Ishii, K., Nakagawa, Y., IWASAKI, H. O., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221663 · Cited by 40
MECHANISMS IN ENDOCRINOLOGY: Hypothalamic inflammation and nutrition
ARAUJO, E. P. D., Moraes, J. C., Cintra, D. E., & Velloso, L. A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1207 · Cited by 39
de Oliveira, C. P. M. S., de Lima, V. M. R., Simplicio, F. I., Soriano, F. G., de Mello, E. S., de Souza, H. P., Alves, V. A. F., Laurindo, F. R. M., Carrilho, F. J., & de Oliveira, M. G. (2008) · Journal of the American College of Nutrition · doi:10.1080/07315724.2008.10719703 · Cited by 39
Petit, J. M., Guiu, B., Duvillard, L., Jooste, V., Brindisi, M., Athias, A., Bouillet, B., Habchi, M., Cottet, V., Gambert, P., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.007 · Cited by 39
Yang, Y., Du, L., Hosokawa, M., & Miyashita, K. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103741 · Cited by 38
Wang, Q., Perrard, X. D., Perrard, J. L., Mansoori, A., Raya, J. L., Hoogeveen, R. C., Smith, C. W., Ballantyne, C. M., & Wu, H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.025 · Cited by 38
Park, H., Liu, Y., Kim, H.-S., & Shin, J.-H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.010 · Cited by 37
Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse
Riordan, J. D., & Nadeau, J. H. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9521-3 · Cited by 36
Non-Alcoholic Fatty Liver Disease, an Overview.
Muhammad, A. (2019) · PubMed Central · Cited by 37
Nutraceuticals in the management of obesity
Nijhawan, P., & Behl, T. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100168 · Cited by 37
Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?
Kotzka, J., & Müller‐Wieland, D. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.2.141 · Cited by 37
Management of Nonalcoholic Steatohepatitis
Mahady, S. E., & George, J. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.003 · Cited by 36
Osman, R. H., Liu, L., Xia, L., Zhao, X., Wang, Q., Sun, X., Zhang, Y., Yang, B., Zheng, Y., Gong, D., et al. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2737-7 · Cited by 36
Dietary walnut oil modulates liver steatosis in the obese Zucker rat
Fink, A., Rüfer, C. E., Grandois, J. L., Röth, A., Werner, D., Marchioni, E., Bub, A., & Barth, S. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0573-z · Cited by 38
n−3 Fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice
Jung, U. J., Millman, P. N., Tall, A. R., & Deckelbaum, R. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.003 · Cited by 36
Sterol regulatory element–binding protein‐1c and pancreatic β‐cell dysfunction
Shimano, H., Amemiya-Kudo, M., Takahashi, A., Kato, T., Ishikawa, M., & Yamada, N. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00779.x · Cited by 35
Promising therapies for treatment of nonalcoholic steatohepatitis
Noureddin, M., Zhang, A., & Loomba, R. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1220533 · Cited by 35
Pioglitazone on nonalcoholic steatohepatitis: A systematic review and meta-analysis of 15 RCTs
Zhao, Y. D., Zhao, W., Wang, H., Zhao, Y., Bu, H., & Takahashi, H. (2022) · Medicine · doi:10.1097/md.0000000000031508 · Cited by 34
Effects of high-fat diet on salivary α-amylase, serum parameters and food consumption in rats
Rodrigues, L., Mouta, R., Costa, A. R., Pereira, A. M. F., Silva, F. C. E., Amado, F. M. L., Antunes, C. M., & Lamy, E. (2015) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.02.015 · Cited by 40
Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease
Ghaemi, A., Hosseini, N., Osati, S., Naghizadeh, M. M., Dehghan, A., Ehrampoush, E., Honarvar, B., & Homayounfar, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-23192-x · Cited by 35
Diet and gut microbiome in fatty liver and its associated liver cancer
Pan, Y., & Zhang, X. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15713 · Cited by 35
Nakakuki, M., Kawano, H., Notsu, T., Imada, K., Mizuguchi, K., & Shimano, H. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu019 · Cited by 34
van Werven, J. R., Schreuder, T. C. M. A., Nederveen, A. J., Lavini, C., Jansen, P. L. M., & Stoker, J. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.12.033 · Cited by 33
Li, S., Huang, Z., Dong, Y., Zhu, R., & Li, T. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.04.030 · Cited by 33
Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis
Santoro, N., Caprio, S., & Feldstein, A. E. (2013) · Clinical Lipidology · doi:10.2217/clp.13.39 · Cited by 33
Probiotics and barrier function in colitis
Gionchetti, P., Lammers, K. M., Rizzello, F., & Campieri, M. (2005) · Gut · doi:10.1136/gut.2004.060640 · Cited by 34
Insight into the Role of LCAT from Mouse Models
Ng, D. S. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000045102.70521.af · Cited by 33
Alwayn, I. P. J., Andersson, C., Lee, S., Arsenault, D. A., Bistrian, B. R., Gura, K. M., Nosé, V., Zauscher, B., Moses, M. A., & Puder, M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00047.2006 · Cited by 33
Environmental and Genetic Determinants of Fatty Liver in Humans
Kantartzis, K., Schick, F., Häring, H., & Stefan, N. (2010) · Digestive Diseases · doi:10.1159/000282082 · Cited by 32
Borengasser, S. J., Rector, R. S., Uptergrove, G. M., Morris, E. M., Perfield, J. W., Booth, F. W., Fritsche, K. L., Ibdah, J. A., & Thyfault, J. P. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2012/268680 · Cited by 32
Kelley, N. S. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0051 · Cited by 32
Petersson, H., Ärnlöv, J., Zethelius, B., & Risérus, U. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.11.019 · Cited by 32
Chen, Y., Xu, C., Yan, T., Yu, C., & Li, Y. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.022 · Cited by 32
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
Ke, C., Xiao, C., Li, J., Wu, X., Zhang, Y., Chen, Y., Sheng, S., Fu, Z., Wang, L., Ni, C., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000643 · Cited by 32
Kim, J. K., Cho, S. M., Kang, S. H., Kim, E., Yi, H., Yun, E. S., Lee, D. G., Cho, H. J., Paik, Y. H., Choi, Y. K., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07227.x · Cited by 31
Kim, H., Lee, K., Park, Y. B., Jeon, S.-M., & Choi, M. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700315 · Cited by 31
Nunzio, M. D., van Deursen, D., Verhoeven, A. J. M., & Bordoni, A. (2009) · British Journal Of Nutrition · doi:10.1017/s000711450999167x · Cited by 31
Pharmacologic Therapy of Non-Alcoholic Steatohepatitis
Ratziu, V., & Zelber‐Sagi, S. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.001 · Cited by 30
Metadata
- Authors
- Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J.-I., Yamada, N., & Shimano, H.
- Affiliations
- The University of Tokyo (JP)
- University of Tsukuba (JP)
- Corresponding author
- Shimano, Hitoshi
- ORCID
- Venue
- Hepatology
- Published
- 2003-12
- Volume
- 38
- Issue
- 6
- Pages
- 1529-1539
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2079378050
- Cited by
- 415
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 12 · 2023: 21 · 2022: 12 · 2021: 17 · 2020: 24 · 2019: 12 · 2018: 16 · 2017: 21 · 2016: 23 · 2015: 25 · 2014: 19 · 2013: 34 · 2012: 17
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- polyunsaturated fatty acids, hepatic steatosis, SREBP1, PPARα, leptin-deficient ob/ob mice, hepatic lipogenesis, fatty acid synthase, stearoyl-CoA desaturase 1, insulin resistance, hyperinsulinemia, hyperglycemia, obesity
- MeSH terms
- Alanine Transaminase, Animals, Cholesterol, DNA-Binding Proteins, Fatty Acids, Unsaturated, Fatty Liver, Gene Expression Regulation, Insulin Resistance, Liver, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Triglycerides, Receptors, Cytoplasmic and Nuclear, CCAAT-Enhancer-Binding Proteins, Mice, Sterol Regulatory Element Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review